CNS & Neurological Disorders - Drug Targets
Title:Meet the Editorial Board
Volume: 14 Issue: 2
Author(s): Mohammad Amjad Kamal
Affiliation:
Export Options
About this article
Cite this article as:
Kamal Amjad Mohammad, Meet the Editorial Board, CNS & Neurological Disorders - Drug Targets 2015; 14 (2) . https://dx.doi.org/10.2174/187152731402150305113014
DOI https://dx.doi.org/10.2174/187152731402150305113014 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
26
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dopamine Receptor Interacting Proteins: Targeting Neuronal Calcium Sensor-1/D2 Dopamine Receptor Interaction for Antipsychotic Drug Development
Current Drug Targets Process Optimization for Biodiesel Production
Recent Patents on Biotechnology Feature Based Fusion of Multimodal Medical Image Slices with Combined Transforms
Current Medical Imaging The Role of FLT3 Kinase as an AML Therapy Target
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Neuropharmacology Spectroscopic and Functional Characterization of Human β-Synuclein
Protein & Peptide Letters Glatiramer Acetate Induced Hepatotoxicity
Current Drug Safety Centralized and Local Color Doppler Ultrasound Reading Agreement for Diagnosis of the Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis
Current Neurovascular Research Stroke and Neuroinflamation: Role of Sexual Hormones
Current Pharmaceutical Design Patients Characteristics and Clinical Implications of Suboptimal CD4 T-Cell Gains After 1 Year of Successful Antiretroviral Therapy
Current HIV Research Recent Trends in Design and Developments of New Drugs for the Treatment of Cancer, Rheumatoid arthritis, and Parkinson’s Disease-Associated to Abnormal Signal Transduction
Current Signal Transduction Therapy Chagas Disease: Progress and New Perspectives
Current Medicinal Chemistry Cholecystokinin 1(A) Receptor Polymorphisms
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member
Current Neuropharmacology Anti-β-Amyloid Immunotherapy for Alzheimers Disease: Focus on Bapineuzumab
Current Alzheimer Research The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases
Current Organic Chemistry FTY720: A Most Promising Immunosuppressant Modulating Immune Cell Functions
Mini-Reviews in Medicinal Chemistry A Hydrazide Linker Strategy for Heterobivalent Compounds as Ortho- and Allosteric Ligands of Acetylcholine-Binding Proteins
Current Topics in Medicinal Chemistry Intra-Renal Hemodynamic Changes After Habitual Physical Activity in Patients with Chronic Kidney Disease
Current Pharmaceutical Design Highly Selective MEK Inhibitors
Current Enzyme Inhibition